NorthWest Biotherapeutics Inc (NWBO)

[jimmy667]

This is not a dumb question and I think it is directly on target. The nature of the trial and the nature of the illness being treated almost assuredly means the results will be somewhere in the middle. This is why it is critical that TLD is released in conjunction with a Peer Reviewed Medical Journal.
Being a finance guy instead of a field expert might be a great advantage. NWBO is a company trying to bring a better treatment for a difficult cancer. Not a get rich quick scheme. So the question for investors should be not how high will NWBO fly when TLD is announced (because the stock could drop precipitously even with good TLD and glowing Journal) but whether NWBO can gain RA approval and be profitable in the long run. Hoping for a quick get rich from a Buy Out or large stock price increase on TLD is not investing It is gambling.
Finance guys I know and successful investors do not gamble.
In Biotech sometimes the best time to buy a particular company is after a trial failure if there is a path forward and there is cash on books so that a near term stock sale/equity raise is unlikely. Hot momo money will sell on binary events good or bad so they can move on to their next gamble.